BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20102352)

  • 1. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.
    Kwok CS; Loke YK
    Aliment Pharmacol Ther; 2010 Apr; 31(8):810-23. PubMed ID: 20102352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study.
    van Boxel OS; van Oijen MG; Hagenaars MP; Smout AJ; Siersema PD
    Am J Gastroenterol; 2010 Nov; 105(11):2430-6; quiz 2437. PubMed ID: 20736935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
    Lanas A
    Gastroenterol Hepatol; 2010 Jan; 33(1):1-5. PubMed ID: 20005015
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
    Tan VP; Yan BP; Hunt RH; Wong BC
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1342-7. PubMed ID: 20659222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversy of proton pump inhibitor and clopidogrel interaction: a review.
    Tan HJ
    J Dig Dis; 2010 Dec; 11(6):334-42. PubMed ID: 21091895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
    Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
    Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome.
    Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A
    Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
    Oyetayo OO; Talbert RL
    Expert Opin Drug Saf; 2010 Jul; 9(4):593-602. PubMed ID: 20377472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
    Leontiadis GI; Yuan Y; Howden CW
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):637-56. PubMed ID: 21944415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.
    Valkhoff VE; 't Jong GW; Van Soest EM; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2011 Jan; 33(1):77-88. PubMed ID: 21083580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
    Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
    Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.